TRS65 Antibody

What is TRS65 and what cellular pathways does it participate in?

TRS65 (also known as KRE11) is one of three TRAPP II-specific subunits involved in multiple cellular processes. Unlike the other two TRAPP II-specific subunits (Trs120 and Trs130), TRS65 is not essential for viability and is conserved only among some fungi . Research indicates TRS65 participates in three main cellular processes:

• Intracellular trafficking: TRS65 functions as part of the TRAPP II complex, which acts as a guanine nucleotide exchanger (GEF) for Ypt31/32, regulating transport out of the Golgi .

• Cell wall biogenesis: The documented defect of TRS65/KRE11 loss-of-function is in cell wall biogenesis, supporting its role in this process .

• Stress response: Mutant phenotypes and genetic interactions suggest TRS65 involvement in stress response pathways .

These multiple functions suggest TRS65 may serve as a coordinator between these cellular processes, making it particularly valuable for studying their interconnections.

How does TRS65 contribute to TRAPP II complex stability and function?

TRS65 plays a crucial role in maintaining the stability and proper function of the TRAPP II complex through several mechanisms:

• Stabilization of TRAPP II components: Loss of TRS65 function results in lower levels of Trs130 protein in both cell lysates and purified TRAPP complexes. When TRS65 is deleted, Trs130-HA protein levels can decrease to approximately 50% at 37°C compared to wild-type cells .

• Maintenance of GEF activity: TRS65 contributes to the Ypt GEF activity of TRAPP II, particularly toward Ypt31/32. TRAPP complexes purified from trs65Δ mutant cells show reduced Ypt31 GEF activity while initially maintaining normal Ypt1 GEF activity .

• Physical interactions: TRS65 interacts physically with both Trs120 and Trs130 in yeast two-hybrid assays, suggesting direct protein-protein interactions that help maintain complex integrity .

• Trans-Golgi localization: TRS65 localizes to the trans-Golgi, similar to Trs130 and Ypt31, helping position the complex at its site of action .

The collective evidence indicates TRS65 helps stabilize and/or localize Trs120 and Trs130 within TRAPP II, which is critical for maintaining proper Ypt GEF activity regulation.

What localization pattern should researchers expect when using TRS65 antibodies for immunofluorescence?

When conducting immunofluorescence studies with TRS65 antibodies, researchers should expect to observe trans-Golgi localization patterns. This has been demonstrated experimentally through fluorescence microscopy using YFP-tagged TRS65 . Specifically:

• TRS65 colocalizes with Sec7-DsRed, a well-established trans-Golgi marker .

• YFP-TRS65 was shown to localize to punctate structures characteristic of the Golgi apparatus in live cell deconvolution microscopy .

• When planning colocalization studies, researchers should consider using established Golgi markers like Sec7-DsRed or Cop1-RFP rather than endosomal markers like DsRed-FYVE .

For optimal visualization, fluorescence microscopy protocols should employ Z-stack imaging (5-10 stacks of approximately 275 nm each) with deconvolution processing using regularized inverse filter techniques to achieve clear resolution of the punctate Golgi structures .

What are the most effective methods for validating TRS65 antibody specificity?

When validating TRS65 antibody specificity, researchers should implement a multi-tiered approach:

• Genetic validation: Use trs65Δ mutant strains as negative controls in all antibody-based experiments. The complete absence of signal in these knockout backgrounds provides definitive evidence of specificity .

• Epitope tagging controls: Compare antibody detection with epitope-tagged versions of TRS65 (e.g., YFP-TRS65 or HA-TRS65) using both the TRS65 antibody and tag-specific antibodies to confirm concordant detection patterns .

• Competitive blocking: Pre-incubate the TRS65 antibody with purified TRS65 peptide/protein before immunostaining to confirm that specific binding is blocked.

• Cross-reactivity assessment: Test the antibody against other TRAPP complex components, particularly those sharing sequence similarity. Focus especially on the other two TRAPP II-specific subunits (Trs120 and Trs130) to ensure no cross-reactivity occurs .

• Multiple application validation: Confirm specificity across multiple applications (Western blot, immunoprecipitation, immunofluorescence) as antibodies may perform differently in various experimental contexts.

For the most robust validation, researchers should demonstrate concordant results between TRS65 antibody detection and functional assays, such as protein interaction studies or GEF activity assessments.

How should researchers optimize immunoprecipitation protocols when studying TRS65 interactions with other TRAPP components?

When optimizing immunoprecipitation (IP) protocols for studying TRS65 interactions with other TRAPP components, researchers should consider several critical factors:

• Buffer composition: Use buffers that preserve protein-protein interactions while efficiently extracting TRAPP complexes. The GST-Bet5 pull-down approach has been successfully used to purify intact TRAPP complexes containing TRS65 .

• Detergent selection: Choose mild, non-ionic detergents (0.1-0.5% NP-40 or Triton X-100) to solubilize membranes while preserving protein-protein interactions within the TRAPP complex.

• Cross-linking consideration: For capturing transient or weak interactions, consider implementing mild cross-linking protocols (0.1-0.5% formaldehyde for 10 minutes) before cell lysis.

• Sequential IP approach: To specifically isolate TRAPP II complexes containing TRS65, consider a sequential IP approach:

  • First IP: Target shared TRAPP I/II components like Bet3 or Bet5

  • Second IP: Target TRS65 specifically
    This approach helps distinguish between TRAPP I and TRAPP II complexes .

• Quantification methods: Implement quantitative Western blotting to assess the relative stoichiometry of TRAPP components in immunoprecipitated complexes. This is especially important when comparing wild-type versus mutant strains, as demonstrated in the study of Trs130 levels in trs65Δ mutants .

• Controls for specificity: Include negative controls (IgG, unrelated antibodies) and perform reverse IPs targeting known interaction partners (Trs120, Trs130) to validate results .

Researchers should be aware that TRAPP complex stability may be temperature-sensitive, as demonstrated by the more severe effects observed at 37°C compared to 26°C in trs65Δ(ts) cells .

What experimental approaches can distinguish between TRS65's roles in trafficking versus cell wall biogenesis?

Distinguishing between TRS65's roles in trafficking and cell wall biogenesis requires multiple complementary experimental approaches:

• Separation-of-function mutations: Generate and characterize point mutations in different domains of TRS65 that may differentially affect its roles in trafficking versus cell wall biogenesis.

• Domain-specific antibodies: Develop antibodies targeting distinct functional domains of TRS65 to selectively inhibit specific functions in in vitro assays.

• Pathway-specific assays:

  • For trafficking: Monitor Hsp150 secretion, which is reduced in trs65Δ(ts) mutants at non-permissive temperatures, or examine Berkeley body formation by electron microscopy .

  • For cell wall biogenesis: Assess sensitivity to cell wall-perturbing agents like Calcofluor White or Congo Red, and measure β-1,6-glucan content.

• Temporal separation: Use temperature-sensitive trs65 mutants and rapid temperature shifts to distinguish immediate effects (likely trafficking) from delayed effects (potentially cell wall biogenesis) .

• Genetic interaction profiling: Compare genetic interaction patterns with known trafficking components versus cell wall biogenesis factors. For example, the fact that Ypt31 overexpression rescues trs65Δ(ts) growth defects suggests a primary connection to trafficking pathways .

• Quantitative proteomics: Compare the composition of TRAPP complexes and cell wall fractions in wild-type versus trs65Δ cells to identify differentially affected protein networks.

By integrating these approaches, researchers can delineate which phenotypic outcomes are direct consequences of trafficking defects versus those stemming from cell wall biogenesis abnormalities.

How does TRS65 loss differentially affect TRAPP complex GEF activity toward Ypt1 versus Ypt31/32?

The differential effect of TRS65 loss on TRAPP complex GEF activity toward different Ypt GTPases reveals important regulatory mechanisms:

• Selective impairment of Ypt31/32 GEF activity: In trs65Δ cells, TRAPP complexes show reduced GEF activity toward Ypt31/32 while maintaining normal Ypt1 GEF activity. This indicates TRS65 specifically contributes to the Ypt31/32 GEF function of TRAPP II .

• Connection to Trs130 levels: The reduced Ypt31/32 GEF activity correlates with lower Trs130 protein levels in TRAPP complexes from trs65Δ cells. This suggests TRS65 may influence GEF specificity indirectly by stabilizing Trs130 .

• Temperature-dependent effects on GEF specificity: In trs65Δ(ts) mutant cells grown at non-permissive temperature (37°C), Ypt31 GEF activity is abolished while Ypt1 GEF activity becomes higher than in wild-type TRAPP. This indicates a complete shift in GEF specificity .

• Sequential functional relationship: The data suggest a hierarchical relationship where:

  • Mild reduction in Trs130 (seen in trs65Δ) affects only Ypt31/32 GEF activity

  • Severe reduction in both Trs120 and Trs130 (seen in trs65Δ(ts) at 37°C) affects both Ypt31/32 and Ypt1 GEF activities

This differential effect provides insight into how TRAPP complexes switch GEF specificity from Ypt1 to Ypt31/32, with TRS65 playing a regulatory role in this process.

What approaches can researchers use to investigate potential phosphorylation or other post-translational modifications of TRS65?

Investigating post-translational modifications (PTMs) of TRS65 requires systematic approaches:

• Mass spectrometry analysis: Employ tandem mass spectrometry (MS/MS) to identify potential phosphorylation sites, ubiquitination, or other PTMs on immunoprecipitated TRS65. Use both bottom-up (tryptic digestion) and middle-down (alternative proteases) approaches for comprehensive coverage.

• Phospho-specific antibodies: Generate antibodies against predicted phosphorylation sites of TRS65, particularly those in regions that interact with Trs120 and Trs130, to monitor phosphorylation status under different cellular conditions.

• Kinase/phosphatase inhibitor studies: Treat cells with specific kinase or phosphatase inhibitors and monitor changes in TRS65 PTM status, localization, and function to identify relevant regulatory pathways.

• Phosphomimetic mutations: Generate phosphomimetic (S/T→D/E) and phosphodeficient (S/T→A) mutations at potential phosphorylation sites to assess functional consequences in vivo.

• Cell cycle and stress response studies: Given TRS65's role in stress response , analyze changes in its PTM profile during different cell cycle stages and after various stress stimuli (heat shock, osmotic stress, cell wall stress).

• Correlation with GEF activity: Measure the correlation between PTM status of TRS65 and TRAPP II GEF activity toward Ypt31/32 to establish functional relevance of the modifications .

• In vitro reconstitution: Develop an in vitro system with purified components to directly test how specific PTMs affect TRS65's interactions with Trs120 and Trs130, and the consequent impact on TRAPP II assembly and GEF activity.

These approaches should be integrated with the knowledge that TRS65 functions in multiple cellular processes, including trafficking, cell wall biogenesis, and stress response .

How can researchers resolve contradictory data between different experimental methods when studying TRS65?

Resolving contradictory data between different experimental approaches in TRS65 research requires systematic troubleshooting:

• Method-specific limitations analysis:

  • Yeast two-hybrid: May detect direct interactions but can produce false positives/negatives due to fusion protein effects

  • Co-immunoprecipitation: Captures physiological complexes but may include indirect interactions

  • Genetic interactions: Reveal functional relationships but don't necessarily indicate physical interactions

• Cellular context considerations:

  • Growth conditions: TRS65 function shows temperature sensitivity, as demonstrated by more severe phenotypes at 37°C versus 26°C

  • Strain background variations: Different yeast strains may have altered dependencies on TRS65

  • Tags and fusion proteins: May interfere with specific functions or interactions

• Biochemical state variability:

  • Complex integrity: TRAPP II complex stability is affected by TRS65 deletion, potentially explaining different outcomes in various assays

  • Conditional interactions: Some TRS65 interactions may be transient or condition-dependent

• Reconciliation strategies:

  • Use orthogonal methods: If yeast two-hybrid and co-IP give different results, add a third method like proximity labeling (BioID)

  • Structural biology approaches: Cryo-EM or X-ray crystallography of TRAPP II complexes can resolve interaction controversies

  • Domain mapping: Identify specific interaction domains to explain partial or context-dependent interactions between TRS65 and other proteins

• Quantitative assessments:

  • Replace qualitative (yes/no) with quantitative measures of interactions

  • Consider stoichiometry and binding affinities, especially given the reduced levels of Trs130 observed in trs65Δ cells

Researchers should remember that TRS65's multifunctional nature in trafficking, cell wall biogenesis, and stress response may naturally lead to context-dependent results that appear contradictory but actually reflect its diverse roles .

What epitope regions of TRS65 should antibodies target for optimal specificity and functionality?

When developing or selecting TRS65 antibodies, researchers should consider several factors regarding epitope selection:

• Functional domain targeting:

  • Target epitopes in regions that don't interfere with protein-protein interactions, particularly avoiding the domains that interact with Trs120 and Trs130

  • For functional studies, consider epitopes outside the regions involved in TRAPP II complex assembly

• Sequence uniqueness:

  • Select epitopes unique to TRS65 with minimal homology to other TRAPP components

  • Avoid regions with sequence similarity to the shared TRAPP I/II subunits (Bet3, Bet5, Trs20, Trs23, Trs31, Trs33)

  • Cross-reference potential epitopes against the fungal proteome to ensure specificity

• Structural accessibility:

  • Choose epitopes likely to be surface-exposed in the native protein

  • Avoid transmembrane or hydrophobic regions that may be inaccessible in the folded protein

  • Consider that TRS65 localizes to the trans-Golgi, suggesting certain domains interact with membranes

• Conservation considerations:

  • For species-specific studies, target variable regions of TRS65

  • For cross-species applications, target epitopes conserved among fungal TRS65 homologs

  • Remember that TRS65 is conserved only among some fungi

• Application-specific targets:

  • For immunoprecipitation: Target larger, more accessible epitopes

  • For immunofluorescence: Select epitopes that remain accessible after fixation procedures

  • For functional blocking: Target regions involved in interactions with Trs120 and Trs130

• Validation approach:

  • Generate multiple antibodies against different epitopes to cross-validate findings

  • Use trs65Δ strains as negative controls to confirm antibody specificity

The optimal approach involves generating multiple antibodies targeting different regions and validating each for specific applications.

What are the recommended fixation and permeabilization protocols for TRS65 immunofluorescence studies?

For optimal TRS65 immunofluorescence detection, researchers should consider these technical recommendations based on successful protocols:

• Fixation options:

  • Formaldehyde fixation (4% for 15-20 minutes) preserves protein localization while maintaining antigenicity

  • For higher resolution studies, consider using a combination of formaldehyde (4%) and a low concentration of glutaraldehyde (0.05%) for better ultrastructural preservation

• Permeabilization approaches:

  • Mild detergent treatment (0.1% Triton X-100 for 5-10 minutes) is typically sufficient for antibody access to Golgi-localized proteins

  • For difficult-to-access epitopes, consider methanol treatment (-20°C for 6 minutes) which provides both fixation and permeabilization

• Buffer considerations:

  • Use phosphate-buffered saline (PBS) for fixation and washing steps

  • For blocking, include 1-3% BSA or normal serum from the secondary antibody species

  • Consider adding 0.1% saponin to all buffers to maintain permeabilization throughout the protocol

• Antigen retrieval:

  • If initial protocols show weak signal, consider mild antigen retrieval (citrate buffer, pH 6.0, 80°C for 20 minutes)

  • Enzymatic retrieval is generally not recommended for Golgi proteins

• Live cell alternatives:

  • For dynamic studies, the YFP-TRS65 approach has been successful in localizing TRS65 to the trans-Golgi

  • Live cell deconvolution microscopy with Z-stacks (5-10 stacks of 275 nm each) provides excellent resolution

• Co-localization markers:

  • Include Sec7-DsRed as a trans-Golgi marker for co-localization studies

  • Cop1-RFP can be used as an additional Golgi marker

  • Avoid endosomal markers like DsRed-FYVE as TRS65 is not expected to co-localize with these

These recommendations are derived from successful protocols used in TRS65 localization studies and general best practices for Golgi protein immunofluorescence.

What quantitative methods should be used to assess TRAPP complex composition changes in response to experimental manipulations?

Quantitative assessment of TRAPP complex composition changes requires rigorous methodological approaches:

• Quantitative immunoblotting:

  • Use fluorescence-based detection systems (like Odyssey) for wider linear range compared to chemiluminescence

  • Include loading controls from different cellular compartments to normalize signals

  • Analyze the relative ratios of TRAPP subunits (e.g., Trs130:Bet3 ratio) rather than absolute levels alone

  • Perform density gradient analysis of the detected bands to obtain precise quantification

• Mass spectrometry-based quantification:

  • SILAC (Stable Isotope Labeling with Amino acids in Cell culture) to compare wild-type vs. experimental conditions

  • TMT (Tandem Mass Tag) labeling for multiplexed comparison across multiple conditions

  • Label-free quantification with appropriate normalization for higher-throughput analyses

  • SRM/MRM (Selected/Multiple Reaction Monitoring) for targeted quantification of specific TRAPP components

• Biochemical fractionation approaches:

  • Size exclusion chromatography to separate intact TRAPP II from TRAPP I or subcomplexes

  • Quantify the distribution of TRS65 and other TRAPP components across fractions

  • Compare elution profiles between wild-type and experimental conditions

• Imaging-based quantification:

  • Fluorescence correlation spectroscopy (FCS) to measure complex formation in live cells

  • Fluorescence resonance energy transfer (FRET) between tagged TRAPP components to assess proximity

  • Ratiometric imaging of differentially tagged components to assess stoichiometry

• Data analysis considerations:

  • Use statistical methods appropriate for ratio data (often requiring log transformation)

  • Apply multiple comparison corrections when analyzing numerous components

  • Develop mathematical models to estimate complex stability based on subunit levels

  • Consider time-course experiments to distinguish between assembly/disassembly versus degradation

• Controls and validations:

  • Use known TRAPP complex perturbations as positive controls (e.g., trs130ts mutants)

  • Validate findings with orthogonal methods (e.g., confirm immunoblot findings with microscopy)

  • Include stoichiometric analyses to distinguish between specific versus non-specific effects

These approaches should be tailored to the specific experimental question, considering that TRS65 deletion affects Trs130 levels differentially depending on temperature and genetic background .

How should researchers interpret changes in GEF activity when studying TRS65 antibody effects?

Interpreting changes in GEF activity when studying TRS65 antibody effects requires careful consideration of several factors:

• Distinguishing direct versus indirect effects:

  • Direct inhibition: Does the antibody directly block TRS65's contribution to the GEF activity?

  • Indirect effects: Does the antibody disrupt TRAPP II complex assembly by blocking TRS65 interactions with Trs120/Trs130?

  • Consider that TRS65 loss reduces Trs130 levels, which may indirectly affect GEF activity

• Substrate-specific analysis:

  • Examine effects on Ypt1 GEF activity separately from Ypt31/32 GEF activity

  • Normal pattern in TRS65 mutants: Reduced Ypt31/32 GEF activity with initially normal Ypt1 GEF activity

  • Under severe conditions: Complete loss of Ypt31/32 GEF activity with increased Ypt1 GEF activity

• Quantitative assessment protocols:

  • Use purified components for in vitro GEF assays to eliminate cellular variables

  • Measure both initial rates and steady-state levels of nucleotide exchange

  • Express results as fold-change relative to control conditions rather than absolute values

• Control experiments:

  • Include non-specific IgG controls at equivalent concentrations

  • Test antibodies against different TRS65 epitopes to distinguish domain-specific effects

  • Use TRAPP complexes from trs65Δ strains as controls to identify antibody off-target effects

• Integrated analysis framework:

  • Correlate GEF activity changes with alterations in complex composition

  • Consider temperature as a variable, as TRS65 function shows temperature sensitivity

  • Relate GEF activity changes to downstream cellular effects (e.g., Golgi morphology, secretory function)

• Mechanistic interpretation models:

  • Threshold model: Partial reduction in Trs130 (as seen in trs65Δ) affects only Ypt31/32 GEF activity

  • Conformational model: TRS65 influences the structural conformation of TRAPP II to favor Ypt31/32 over Ypt1

  • Localization model: TRS65 may help position TRAPP II at specific Golgi subdomains for optimal Ypt31/32 GEF activity

These considerations will help researchers accurately interpret GEF activity data in the context of TRS65 antibody studies or mutations.

What genetic interaction patterns would suggest functional TRS65 antibody specificity?

Genetic interaction patterns can provide powerful validation of TRS65 antibody specificity and functional effects through the following framework:

• Expected genetic interactions for functional TRS65 inhibition:

  • Synthetic growth defects with TRAPP I/II shared subunits, especially Trs33

  • Synthetic interactions with trs120 and trs130 mutations

  • Rescue by overexpression of Ypt31, but not Ypt1

  • Aggravation of growth defects in combination with cell wall integrity pathway mutants

• Antibody validation through genetic mimicry:

  • A truly specific and functional TRS65 antibody should produce phenotypes similar to trs65Δ when introduced into cells

  • The antibody effect should be suppressed by overexpression of Ypt31

  • The antibody should exacerbate growth defects of trs120 or trs130 partial loss-of-function mutants

• Epitope-specificity confirmation:

  • Different antibodies targeting distinct TRS65 epitopes may show different genetic interaction profiles

  • Antibodies targeting interaction domains between TRS65 and Trs120/Trs130 should show stronger genetic interactions with those pathways

  • Genetic interaction patterns may reveal domain-specific functions of TRS65

• Cross-pathway validation:

  • Test for expected genetic interactions with cell wall biogenesis pathways (e.g., FKS1, KRE6)

  • Examine genetic interactions with stress response pathways

  • The specific pattern of cross-pathway interactions can fingerprint whether an antibody is affecting all or only some TRS65 functions

• Quantitative interaction mapping:

  • Use quantitative fitness measurements rather than binary growth/no-growth assessments

  • Compare the strength of genetic interactions between antibody treatment and trs65Δ

  • Consider temperature-dependence of interactions, testing at both permissive and restrictive temperatures

A truly specific functional antibody should reproduce the genetic interaction profile of trs65Δ, while an antibody affecting only a subset of TRS65 functions may show a more restricted interaction pattern. This approach can help validate antibodies and potentially identify domain-specific blocking antibodies.

How can TRS65 antibodies be used to study the relationship between membrane trafficking and cell wall stress responses?

TRS65 antibodies provide powerful tools for investigating the interconnection between membrane trafficking and cell wall stress responses:

• Spatial-temporal analysis of TRS65 redistribution:

  • Use immunofluorescence with TRS65 antibodies to track its localization changes during cell wall stress

  • Monitor potential relocalization from trans-Golgi to other compartments under stress conditions

  • Combine with markers for cell wall synthesis enzymes to identify coordination points

• Protein complex remodeling studies:

  • Immunoprecipitate TRS65-containing complexes before and after cell wall stress

  • Identify stress-induced changes in TRAPP II composition and associated proteins

  • Compare with known trs65Δ effects on Trs130 levels to determine if stress mimics loss of TRS65

• Functional inhibition experiments:

  • Use membrane-permeable TRS65 antibodies or antibody fragments to acutely inhibit TRS65 function

  • Compare trafficking defects versus cell wall integrity defects to establish causality

  • Determine if trafficking defects precede cell wall defects, supporting a model where TRS65's role in cell wall biogenesis is secondary to its trafficking function

• Pathway intersection mapping:

  • Combine TRS65 antibody inhibition with chemical inhibitors of:

    • Cell wall synthesis (e.g., Calcofluor White)

    • Secretory trafficking (e.g., Brefeldin A)

  • Analyze epistatic relationships to determine pathway order

• Cargo-specific trafficking analysis:

  • Track how TRS65 antibody treatment affects trafficking of:

    • Cell wall synthesis enzymes

    • Cell wall components

    • Stress response factors

  • Compare with general secretory cargos like Hsp150, which shows reduced secretion in trs65Δ(ts) cells

• Visualization of structural connections:

  • Use super-resolution microscopy with TRS65 antibodies to visualize potential physical connections between TRAPP II complexes and cell wall synthesis machinery

  • Perform proximity labeling experiments (BioID or APEX) using TRS65 as bait to identify proteins at the interface of trafficking and cell wall processes

These approaches leverage TRS65 antibodies to dissect the mechanistic relationships between TRS65's multiple functions, potentially revealing how cells coordinate membrane trafficking with cell wall synthesis and stress responses .

What experimental designs can test whether TRS65's multiple functions operate independently or through a common mechanism?

Testing whether TRS65's functions in trafficking, cell wall biogenesis, and stress response operate independently or through common mechanisms requires sophisticated experimental designs:

• Domain-selective antibody inhibition:

  • Generate antibodies against different TRS65 domains

  • Test whether domain-specific inhibition selectively affects certain functions

  • Compare phenotypic profiles to determine if complete inhibition creates synergistic effects beyond individual domain inhibition

• Temporal dissection experiments:

  • Design rapid induction/inhibition systems (e.g., auxin-inducible degron tagged TRS65)

  • Monitor the timing of defects across different processes:

    • Immediate effects: Likely direct roles

    • Delayed effects: Potentially secondary consequences

  • Compare with temperature shift experiments in trs65Δ(ts) cells, which revealed both immediate trafficking defects and Berkeley body formation

• Cargo-specific trafficking assays:

  • Track transport of different cargo classes:

    • Standard secretory cargo (Hsp150)

    • Cell wall biosynthesis enzymes

    • Stress response proteins

  • Determine if TRS65 inhibition affects all cargo equally or shows selectivity

• Biochemical activity separation:

  • Test whether TRS65's contribution to TRAPP II GEF activity can be separated from its cell wall functions

  • Examine if recombinant TRS65 fragments can complement specific aspects of trs65Δ phenotypes

  • Determine if the reduced Trs130 protein levels in trs65Δ cells fully explain all phenotypic outcomes

• Epistasis analysis with multiple pathways:

  • Combine TRS65 manipulation with inhibition of:

    • Other TRAPP II components (Trs120, Trs130)

    • Downstream GTPases (Ypt1, Ypt31/32)

    • Cell wall integrity pathway components

    • Stress response factors

  • Map independence versus intersection of pathways based on epistatic relationships

• Systems-level analysis:

  • Perform transcriptome and proteome profiling after TRS65 inhibition

  • Apply network analysis to identify whether affected genes/proteins cluster in distinct pathways or in a common network

  • Compare with similar analyses of trs120 and trs130 mutants to identify TRS65-specific effects

• Structural biology approaches:

  • Determine if TRS65 contains structurally and functionally distinct domains

  • Use cryo-EM to visualize how TRS65 interacts with both TRAPP II components and potential cell wall biosynthesis machinery

These experimental designs can distinguish between a model where TRS65 serves as a multifunctional coordinator versus a model where it has evolved separate, independent functions in different cellular processes .

What proteomics approaches can identify novel TRS65-interacting proteins beyond the known TRAPP complex?

Advanced proteomics approaches can uncover novel TRS65-interacting proteins and expand our understanding of its multifunctional nature:

• Proximity-dependent labeling:

  • BioID fusion: Generate TRS65-BirA* fusion proteins to biotinylate proximal proteins

  • APEX2 fusion: Create TRS65-APEX2 for peroxidase-based proximity labeling

  • TurboID: Employ faster biotin ligase variants for capturing transient interactions

  • These approaches can identify proteins in physical proximity to TRS65 beyond those stable enough for co-immunoprecipitation

• Cross-linking mass spectrometry (XL-MS):

  • Apply protein cross-linkers of various spacer lengths to stabilize transient interactions

  • Use MS-cleavable cross-linkers to facilitate identification of cross-linked peptides

  • Map interaction interfaces by identifying specific cross-linked residues between TRS65 and partners

  • This approach could reveal detailed information about how TRS65 interacts with Trs120 and Trs130

• Quantitative interaction proteomics:

  • SILAC immunoprecipitation to compare TRS65 interactors under different conditions:

    • Normal growth versus cell wall stress

    • Different temperatures (26°C versus 37°C)

    • Different growth phases

  • TMT labeling for multiplexed comparison across numerous conditions

• Targeted protein complex analysis:

  • Size exclusion chromatography combined with mass spectrometry (SEC-MS)

  • Blue native PAGE followed by mass spectrometry to identify intact complexes

  • These approaches can reveal whether TRS65 exists in complexes distinct from canonical TRAPP II

• Interactome mapping across cellular conditions:

  • Compare TRS65 interactors during:

    • Cell wall stress response

    • Secretory pathway stress

    • Different cell cycle stages

  • Identify condition-specific interactions that might explain TRS65's multifunctional nature

• Domain-specific interaction mapping:

  • Generate truncated TRS65 constructs to identify domain-specific interactions

  • Compare interactome maps of different domains to identify function-specific binding partners

  • This approach could separate trafficking-related from cell wall biogenesis-related interactors

These proteomics approaches could reveal connections between TRS65 and previously unknown pathways, potentially explaining how this protein functions in trafficking, cell wall biogenesis, and stress response through distinct protein-protein interactions .

How can researchers develop models to study the evolutionary specialization of TRS65 among fungal species?

Developing models to study TRS65 evolutionary specialization requires integrative approaches spanning bioinformatics, genetics, and functional characterization:

• Comparative genomics framework:

  • Construct comprehensive phylogenetic trees of TRS65 homologs across fungi

  • Identify conserved domains versus rapidly evolving regions

  • Map when TRS65 first appeared in fungal evolution, given that it's conserved only among some fungi

  • Correlate TRS65 presence/absence with species-specific traits (cell wall composition, growth habits)

• Domain conservation analysis:

  • Identify domains most conserved across species (likely core functional regions)

  • Detect species-specific insertions/deletions that might represent functional adaptations

  • Map conservation patterns onto structural models to identify surface-exposed adapted regions

• Cross-species complementation experiments:

  • Replace S. cerevisiae TRS65 with homologs from diverse fungi

  • Test complementation of trafficking, cell wall, and stress response phenotypes

  • Identify which functions are universally conserved versus species-specific

• Chimeric protein analysis:

  • Create chimeric proteins with domains from different fungal TRS65 homologs

  • Test which domains confer which functions in S. cerevisiae

  • Generate antibodies against conserved versus variable regions to probe function

• Correlation with cell wall composition:

  • Compare TRS65 sequence features with known differences in fungal cell wall composition

  • Test hypothesis that TRS65 specialization relates to species-specific cell wall requirements

  • Examine if TRS65 interacts with different cell wall synthesis enzymes in different species

• TRAPP complex composition comparison:

  • Determine if TRS65-containing TRAPP complexes have different compositions in different fungi

  • Test whether TRS65's interaction with Trs120 and Trs130 is conserved across species

  • Examine if the effect of TRS65 on Trs130 stability is a conserved mechanism

• Molecular evolution rate analysis:

  • Calculate selection pressure (dN/dS ratios) across different TRS65 domains

  • Identify regions under positive selection (rapidly evolving) versus purifying selection

  • Correlate selection patterns with functional domains to predict adaptive regions

These approaches can reveal how TRS65 has evolved specialized functions in different fungal lineages and provide insight into how proteins can acquire new roles while maintaining core functions across evolution.